Skip to main content
. 2021 Nov 26;21(6):479–506. doi: 10.17245/jdapm.2021.21.6.479

Fig. 5. Subgroup analyses for (a) differences of change in Pain Disability Index from baseline on a 0-70 scale; (b) differences in post-treatment McGill Pain Questionnaire Visual Analog Scale score on a 0-100 scale. CBD, cannabidiol; CBDV, cannabidivarin; CI, confidence interval; THC, tetrahydrocannabinol; VAS, visual analog scale.

Fig. 5